Catalyst Wire Dossier Catalyst Wire Dossier

Combivent Respimat

ipratropium bromide and albuterol sulfate · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Combivent Respimat, covering 2010-11-23 to 2020-09-27. Get the full timeline:

Most recent: FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

See pricing